These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 10711322)
1. The effect of a closed formulary on prescription drug use and costs. Motheral BR; Henderson R Inquiry; 1999-00 Winter; 36(4):481-91. PubMed ID: 10711322 [TBL] [Abstract][Full Text] [Related]
2. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Motheral BR; Henderson R Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412 [TBL] [Abstract][Full Text] [Related]
3. Controlling prescription drug expenditures: a report of success. Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828 [TBL] [Abstract][Full Text] [Related]
4. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411 [TBL] [Abstract][Full Text] [Related]
5. The effect of incentive-based formularies on prescription-drug utilization and spending. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430 [TBL] [Abstract][Full Text] [Related]
6. The effects of copayments and generic substitution on the use and costs of prescription drugs. Smith DG Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607 [TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
8. Managing prescription drug costs. Sica JM Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515 [TBL] [Abstract][Full Text] [Related]
9. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program. Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608 [TBL] [Abstract][Full Text] [Related]
11. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432 [TBL] [Abstract][Full Text] [Related]
12. Expenditures for prescription drugs: too much or not enough? Schumock GT; Walton SM Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578 [TBL] [Abstract][Full Text] [Related]
13. Prescription drugs: issues of cost, coverage, and quality. Copeland C EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445 [TBL] [Abstract][Full Text] [Related]
14. The effect of a three-tier formulary on antidepressant utilization and expenditures. Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214 [TBL] [Abstract][Full Text] [Related]
19. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors. Wang YR; Pauly MV Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891 [TBL] [Abstract][Full Text] [Related]
20. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]